Skip to main content

QWEST CORP

For the period ended Jun 30, 2024. Filed Aug 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 6, 2024

CTGG$12.80+0.2%Stored close · as of Nov 6, 2026

What changed in Risk Factors?

Read the current filing

Previous report: 10-Q

Period ended 2024-03-31; filed 2024-04-30.

0000068622-24-000007

Item 1A. Risk Factors

Current report: 10-Q

Period ended 2024-06-30; filed 2024-08-06.

0000068622-24-000012

Item 1A. Risk Factors

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 4 previous paragraphs and 1 current paragraphs.

0 unchanged; 1 reworded; 0 added; 3 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Removed paragraphs (3)

Previous report

Our affiliates may not realize some or all of the anticipated benefits from completing our debt transactions on March 22, 2024.

Previous report

On March 22, 2024, Lumen, Level 3 and we completed transactions contemplated under our amended and restated transaction support agreement dated as of January 22, 2024, including extending the maturities of a substantial portion of Lumen’s consolidated near-term debt obligations, obtaining new credit facilities and raising $1.325 billion in new Level 3 debt capital. In connection with announcing the closing of these transactions, we indicated that they would provide Lumen and its subsidiaries with additional time to transform their operations and improve their consolidated financial performance.

Previous report

In completing these transactions, Lumen and its subsidiaries incurred substantial transaction expenses, agreed to pay higher levels of interest and committed to more restrictive debt covenants, which collectively could have important consequences, including (i) limiting the ability of Lumen and its subsidiaries to obtain additional financing to fund future debt maturities, working capital, capital expenditures, acquisitions or other general corporate requirements, and increasing their cost of borrowing; (ii) requiring a substantial portion of their cash flows to be dedicated to payments on debt obligations instead of for other purposes; and (iii) various other potentially adverse consequences of carrying significant debt, as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023. Moreover, the extension of Lumen’s consolidated debt maturities may not afford it a sufficient amount of time to implement its transformation plans. For all these reasons and more, Lumen and its subsidiaries may not realize some or all of the anticipated benefits from completing the March 22, 2024 transactions.
Reworded paragraphs (1)

Previous wording

Our operations and financial results are subject to various risks and uncertainties, which could adversely affect our business, financial condition or future results. We recommend that you carefully consider (i) the other information set forth in this report and (ii) the risk factors discussed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023, which are supplemented by the disclosure immediately below:

Current wording

Our operations and financial results are subject to various risks and uncertainties, which could adversely affect our business, financial condition or future results. We recommend that you carefully consider (i) the other information set forth in this report and (ii) the risk factors discussed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023, as supplemented by the disclosures included in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024.